Mitoxantrone resistance due to BCRP overexpression is not limited to colon cancer cells; it has also been observed in other cancer cell lines, such as gastric carcinoma, non-small cell lung cancer, breast cancer, myeloma, fibrosarcoma, and glioblastoma [61,62,63]. This evidence concerns the gene ABCG2 and colonic neoplasm.